
Converge Bio raises $25M, backed by Bessemer and execs from Meta, OpenAI, Wiz
14/01/2026
0:00
7:39
AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional backing from executives at Meta, OpenAI, and Wiz.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
Mais episódios de "TechCrunch Startup News"



Não percas um episódio de “TechCrunch Startup News” e subscrevê-lo na aplicação GetPodcast.







